Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Mosseri Marlio Charles. Officer active across 1 company, notably Nuvectis Pharma, Inc.. Cumulatively, 26 disclosures have been recorded. Split: 26 buys · 0 sell. Total volume traded: €4.5m. Activity tracked since 15 June 2023. The latest transaction was disclosed on 23 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mosseri Marlio Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,700 shares@ US$17.755.0% of flowCommon StockSEC:0001104659-23-072614:0
Canonical exit: 14 Sept 2023 (T+90)
25 of 26 declarations
About Mosseri Marlio Charles
Mosseri Marlio Charles is a declarant linked to Nuvectis Pharma, Inc. He has 26 filings in total, and in the recent filings tracked, the transactions are acquisitions, with EUR 4,450,715 of buys and EUR 0 of sells between 2023-06-16 and 2025-10-29.